RecruitingPhase 3NCT04047628
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Evanston, IL · +22 more sites
Clinical trials in Evanston, IL
37 recruiting studies have a site in or near Evanston, IL, Illinois.
Top conditions here
- Lung Cancer (6)
- Breast Cancer (6)
- Leukemia (5)
- Prostate Cancer (4)
- Parkinson's Disease (3)
- Alzheimer's Disease (2)
- COPD (2)
- Crohn's Disease (2)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 37 of 37 studies
RecruitingPhase 3NCT03150693
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Alton, IL · Burr Ridge, IL · Chicago, IL · +452 more sites
RecruitingPhase 3NCT04267848
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Sponsor: National Cancer Institute (NCI)
Alton, IL · Aurora, IL · Barrington, IL · +1147 more sites
RecruitingPhase 3NCT07190209
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Sponsor: Sanofi
Chicago, IL · Chicago Ridge, IL · Evanston, IL · +72 more sites
RecruitingPhase not listedNCT04706663
Precision-Based Genomics in Prostate Cancer
Sponsor: National Cancer Institute (NCI)
Evanston, IL · +10 more sites
RecruitingPhase 2NCT05554393
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Sponsor: National Cancer Institute (NCI)
Centralia, IL · Chicago, IL · +172 more sites
RecruitingPhase 2NCT06317649
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Sponsor: National Cancer Institute (NCI)
Chicago, IL · +222 more sites
RecruitingPhase 3NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor: Merck Sharp & Dohme LLC
Chicago, IL · Evanston, IL · +84 more sites
RecruitingPhase 2NCT06672146
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Sponsor: National Cancer Institute (NCI)
Chicago, IL · +132 more sites
RecruitingPhase 3NCT06989112
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Sponsor: AstraZeneca
Arlington Heights, IL · Evanston, IL · +61 more sites
RecruitingPhase 1NCT07310420
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Sponsor: TerSera Therapeutics LLC
Chicago, IL · Evanston, IL · Lisle, IL · +23 more sites
RecruitingPhase 3NCT07595549
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Sponsor: Pfizer
Chicago, IL · Evanston, IL · +32 more sites
RecruitingPhase 3NCT06878261
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Sponsor: AstraZeneca
Evanston, IL · Hinsdale, IL · Springfield, IL · +77 more sites
RecruitingPhase 3NCT07174336
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Sponsor: Eli Lilly and Company
Chicago, IL · +126 more sites
RecruitingPhase 3NCT06997497
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Sponsor: Merck Sharp & Dohme LLC
Evanston, IL · Lisle, IL · +46 more sites
RecruitingPhase not listedNCT07143669
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Sponsor: Blueprint Medicines Corporation
Evanston, IL · Normal, IL · +23 more sites
RecruitingPhase not listedNCT07101094
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Sponsor: Bristol-Myers Squibb
Evanston, IL · +19 more sites
RecruitingPhase 3NCT07361497
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Sponsor: Bristol-Myers Squibb
Chicago, IL · Evanston, IL · Peoria, IL · +35 more sites
RecruitingPhase not listedNCT06433752
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Sponsor: TG Therapeutics, Inc.
Chicago, IL · Evanston, IL · +106 more sites
RecruitingPhase 3NCT06767514
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Sponsor: Summit Therapeutics
Carterville, IL · Chicago, IL · +94 more sites
RecruitingPhase not listedNCT04994015
Parkinson's Foundation PD GENEration Genetic Registry
Sponsor: Parkinson's Foundation
Chicago, IL · +60 more sites
RecruitingNot applicableNCT06112860
OTC Hearing Aid and MCI
Sponsor: Northwestern University
Evanston, IL · +2 more sites
RecruitingPhase 2NCT07005154
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Sponsor: Astellas Pharma Global Development, Inc.
Chicago Ridge, IL · Evanston, IL · +10 more sites
RecruitingPhase 3NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor: NRG Oncology
Alton, IL · Aurora, IL · +1223 more sites
RecruitingPhase 2NCT05726292
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Sponsor: University of Chicago
Chicago, IL · Evanston, IL · +2 more sites
RecruitingPhase 3NCT04664634
A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson's
Sponsor: Northwestern University
Evanston, IL
RecruitingPhase 3NCT05812807
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Sponsor: Alliance for Clinical Trials in Oncology
Aurora, IL · Barrington, IL · +825 more sites
RecruitingPhase 2NCT06004674
Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project
Sponsor: Endeavor Health
Evanston, IL
RecruitingPhase 2 / Phase 3NCT03851445
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Sponsor: SWOG Cancer Research Network
Alton, IL · Aurora, IL · +1226 more sites
RecruitingNot applicableNCT04240561
Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
Sponsor: Northwestern University
Chicago, IL · Evanston, IL
RecruitingPhase 2NCT06456593
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Sponsor: Abivax S.A.
Evanston, IL · +42 more sites
RecruitingPhase not listedNCT03448926
The PREDICT Registry:
Sponsor: PreludeDx
Evanston, IL · +29 more sites
RecruitingNot applicableNCT06196008
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
Sponsor: City of Hope Medical Center
Evanston, IL · +15 more sites
RecruitingPhase not listedNCT05236114
GEMINI-NSCLC: NSCLC Biomarker Study
Sponsor: Tempus AI
Carterville, IL · Decatur, IL · Evanston, IL · +55 more sites
RecruitingPhase 2NCT05806515
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Sponsor: SWOG Cancer Research Network
Evanston, IL · Glenview, IL · Highland Park, IL · +130 more sites
RecruitingPhase 3NCT05929768
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Sponsor: SWOG Cancer Research Network
Alton, IL · Aurora, IL · +952 more sites
RecruitingNot applicableNCT05650658
Left vs Left Randomized Clinical Trial
Sponsor: Baylor College of Medicine
Chicago, IL · Evanston, IL · +54 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.